Drugs / ANP
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT00212056 Comparator | Oct 2001 → Dec 2005 | acute myocardial infarction | National Cerebral and Cardiovascular Center, Japan | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ANP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00212056 ↗ |
| Known as | hANP | “ANP(hANP)” NCT00212056 ↗ |
| Modality | Peptide | “atrial natriuretic peptide (ANP)” NCT00212056 ↗ |
| Route | Intravenous | “0∙025 μg/kg per min for 3 days(intravenous)” NCT00212056 ↗ |